Clinical Trial Update: A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• Timolol (timolol)

Snippet

Sponsor: Pfizer | Conditions: Glaucoma, Open Angle Glaucoma | Phase 3 | Status: COMPLETED